In-Hyun Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
In-Hyun Park has a total of 326 co-authors. Here are the top co-authors by number of shared publications:
Yoshiaki Tanaka
Department of Genetics, Yale Stem Cell Center, Wu Tsai Institute, Child Study Center, Yale School of Medicine, New Haven, CT 06520, USA
21 shared publications- Yangfei Xiang
School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China; State Key Laboratory of Advanced Medical Materials and Devices, ShanghaiTech University, Shanghai 201210, China; Shanghai Clinical Research and Trial Center, Shanghai 201210, China
18 shared publications Kun-Yong Kim
Department of Genetics, Pediatrics, Neuroscience, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA
17 shared publicationsFerdi Ridvan Kiral
Department of Genetics and Neuroscience, Yale Stem Cell Center, Child Study Center, Wu Tsai Institute, Yale School of Medicine, New Haven, USA
16 shared publicationsMei Zhong
Yale Stem Cell Center, Yale School of Medicine, New Haven, CT, USA
13 shared publicationsBenjamin Patterson
Department of Genetics, Yale Stem Cell Center, Wu Tsai Institute, Child Study Center, Yale School of Medicine, New Haven, CT 06520, USA
12 shared publications
Latest Publications
- 2 November 2026
- Published by Springer Nature in Nature Reviews Bioengineering
- p. 1-19
Functional readouts of neural organoids
- 2 November 2026
- Published by Springer Nature in Nature Reviews Bioengineering
- p. 1-19
Functional readouts of neural organoids
- Open Access
- 20 October 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (43)
CX3CL1 (fractalkine)–CX3CR1 interface drives CD8⁺ T cell–induced neurodegeneration in human brain organoids
Immune–neuron interactions play a critical role in neuroinflammatory and neurodegenerative diseases, such as Alzheimer’s disease (AD), but how CD8⁺ T cells contribute to brain pathology remains poorly understood. Amyloid-β (Aβ), a hallmark of AD, is known to trigger neuronal stress and inflammation. Here, we established a human cortical organoid (hCO) model to investigate CD8⁺ T cell responses to Aβ-induced neurodegenerative stress. Aβ exposure increased neuronal expression of CX3CL1 (fractalkine), which engages its receptor CX3CR1 on CD8⁺ T cells. Transwell migration assays showed enhanced recruitment of CX3CR1⁺ CD8⁺ T cells toward Aβ-treated hCOs. In parallel, Aβ upregulated IL-15 expression, a cytokine that supports CD8⁺ T cell activation. The infiltration of CD8⁺ T cells led to neuronal injury, marked by MAP2 loss and cleaved Caspase-3 activation, accompanied by an increase in gene signatures for cell death and inflammation. Exposure to the conditioned medium of activated CX3CR1 high CD8⁺ T cell recapitulated this damage, and the neutralization of CD8 + T cell cytokines and cytotoxic molecules rescued the phenotype. These findings identify the CX3CL1–CX3CR1 axis and CD8⁺ T cell effector programs as drivers of neurotoxicity and establish brain organoids as a platform to study immune-driven neurodegeneration.
- 20 October 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (43)
Open AccessCX3CL1 (fractalkine)–CX3CR1 interface drives CD8⁺ T cell–induced neurodegeneration in human brain organoids
Immune–neuron interactions play a critical role in neuroinflammatory and neurodegenerative diseases, such as Alzheimer’s disease (AD), but how CD8⁺ T cells contribute to brain pathology remains poorly understood. Amyloid-β (Aβ), a hallmark of AD, is known to trigger neuronal stress and inflammation. Here, we established a human cortical organoid (hCO) model to investigate CD8⁺ T cell responses to Aβ-induced neurodegenerative stress. Aβ exposure increased neuronal expression of CX3CL1 (fractalkine), which engages its receptor CX3CR1 on CD8⁺ T cells. Transwell migration assays showed enhanced recruitment of CX3CR1⁺ CD8⁺ T cells toward Aβ-treated hCOs. In parallel, Aβ upregulated IL-15 expression, a cytokine that supports CD8⁺ T cell activation. The infiltration of CD8⁺ T cells led to neuronal injury, marked by MAP2 loss and cleaved Caspase-3 activation, accompanied by an increase in gene signatures for cell death and inflammation. Exposure to the conditioned medium of activated CX3CR1 high CD8⁺ T cell recapitulated this damage, and the neutralization of CD8 + T cell cytokines and cytotoxic molecules rescued the phenotype. These findings identify the CX3CL1–CX3CR1 axis and CD8⁺ T cell effector programs as drivers of neurotoxicity and establish brain organoids as a platform to study immune-driven neurodegeneration.
- Open Access
- 7 October 2026
- Published by Elsevier in Cell Reports
- Vol. 45 (10)
CAR-engineered microglia harness phagocytosis to target brain tumor in organoid models
- 7 October 2026
- Published by Elsevier in Cell Reports
- Vol. 45 (10)
Open AccessCAR-engineered microglia harness phagocytosis to target brain tumor in organoid models
- 11 September 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (37)
Elucidating the role of DEAF1 in neurodevelopment and shared molecular pathways in high-risk autism genes using cortical organoids
Neurodevelopmental disorders (NDDs), including autism spectrum disorder (ASD) and intellectual disability (ID), are genetically heterogeneous. DEAF1 has emerged as a key NDD risk gene, with pathogenic variants linked to DEAF1-associated neurodevelopmental disorder (DAND), but its role in human neurodevelopment remains unclear. Human cortical organoids (hCOs) provide a physiologically relevant model that recapitulates fetal brain development with an authentic human genetic background. Here, we show that a DEAF1 mutation in human embryonic stem cells disrupts chromatin accessibility at neuronal gene loci, leading to significant transcriptional alterations. In hCOs, this mutation results in aberrant progenitor proliferation, disrupted cortical lamination, and impaired neuronal differentiation. Furthermore, we identify WNT signaling, TGFβ superfamily signaling, and cell cycle regulation as commonly dysregulated pathways across multiple ASD-associated genetic perturbations. Pharmacological inhibition of WNT signaling with a Porcupine inhibitor partially rescues phenotypic defects in DEAF1-mutant hCOs. Our findings identify DEAF1 as a critical regulator of neurodevelopment and support pathway-targeted, mutation-independent therapeutic strategies for ASD and related disorders.
- 11 September 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (37)
Elucidating the role of DEAF1 in neurodevelopment and shared molecular pathways in high-risk autism genes using cortical organoids
Neurodevelopmental disorders (NDDs), including autism spectrum disorder (ASD) and intellectual disability (ID), are genetically heterogeneous. DEAF1 has emerged as a key NDD risk gene, with pathogenic variants linked to DEAF1-associated neurodevelopmental disorder (DAND), but its role in human neurodevelopment remains unclear. Human cortical organoids (hCOs) provide a physiologically relevant model that recapitulates fetal brain development with an authentic human genetic background. Here, we show that a DEAF1 mutation in human embryonic stem cells disrupts chromatin accessibility at neuronal gene loci, leading to significant transcriptional alterations. In hCOs, this mutation results in aberrant progenitor proliferation, disrupted cortical lamination, and impaired neuronal differentiation. Furthermore, we identify WNT signaling, TGFβ superfamily signaling, and cell cycle regulation as commonly dysregulated pathways across multiple ASD-associated genetic perturbations. Pharmacological inhibition of WNT signaling with a Porcupine inhibitor partially rescues phenotypic defects in DEAF1-mutant hCOs. Our findings identify DEAF1 as a critical regulator of neurodevelopment and support pathway-targeted, mutation-independent therapeutic strategies for ASD and related disorders.
- 22 June 2026
- Published by Springer Nature in Nature Methods
- Vol. 23 (7) , 1399-1410
Derivation of elephant induced pluripotent stem cells
Biodiversity loss in the present era requires new tools for studying nonmodel organisms. Elephants are both an endangered species and excellent models for studying complex phenotypes including size, social behavior and longevity. Here we report the first derivation of elephant (Elephas maximus) induced pluripotent stem (emiPS) cells. We achieved emiPS cells using two approaches: (1) a two-step process of chemical media induction and colony selection followed by over-expression of elephant transcription factors; and (2) a one-step process with transcription factors and HRAS mutant, HRASG12V. For both protocols, we inhibited TP53 retrogenes, which are hypothesized to confer unique cancer resistance in elephants. To confirm their reprogrammed state, we generated a functional omics catalog of emiPS cells. While these emiPS cells remain transgene-dependent, we inactivated the transgenes and differentiated emiPS cells into all three germ layers via tri-lineage differentiation, embryoid body generation and direct differentiation into putative cell types from all three layers. These methods will open new frontiers for cellular models of nonmodel organisms, including for genetic rescue and conservation.
- 22 June 2026
- Published by Springer Nature in Nature Methods
- Vol. 23 (7) , 1399-1410
Derivation of elephant induced pluripotent stem cells
Biodiversity loss in the present era requires new tools for studying nonmodel organisms. Elephants are both an endangered species and excellent models for studying complex phenotypes including size, social behavior and longevity. Here we report the first derivation of elephant (Elephas maximus) induced pluripotent stem (emiPS) cells. We achieved emiPS cells using two approaches: (1) a two-step process of chemical media induction and colony selection followed by over-expression of elephant transcription factors; and (2) a one-step process with transcription factors and HRAS mutant, HRASG12V. For both protocols, we inhibited TP53 retrogenes, which are hypothesized to confer unique cancer resistance in elephants. To confirm their reprogrammed state, we generated a functional omics catalog of emiPS cells. While these emiPS cells remain transgene-dependent, we inactivated the transgenes and differentiated emiPS cells into all three germ layers via tri-lineage differentiation, embryoid body generation and direct differentiation into putative cell types from all three layers. These methods will open new frontiers for cellular models of nonmodel organisms, including for genetic rescue and conservation.
- 25 May 2026
- Published by Elsevier in Cell Stem Cell
- Vol. 33 (7) , 1144-1160.e9
Human amygdala-like telencephalic organoids model stress circuitry in assembloid systems
- 25 May 2026
- Published by Elsevier in Cell Stem Cell
- Vol. 33 (7) , 1144-1160.e9
Human amygdala-like telencephalic organoids model stress circuitry in assembloid systems
- Open Access
Dysregulation of Hippo Signaling Pathway as a Convergent Mechanism Underlying Choroid Plexus Defects in Bipolar Disorder
Bipolar disorder (BD) is a prevalent and highly heritable psychiatric condition. Developmental mechanisms are implicated but the specific molecular origins remain unclear. The choroid plexus (ChP), which regulates cerebrospinal fluid (CSF) and brain homeostasis, has been implicated in BD, but its role is poorly understood. Here, we identify aberrant expansion of ChP in human cortical (hCOs) and ChP organoids (hChPOs) derived from, and in vivo structural magnetic resonance imaging (sMRI) scans of, individuals with BD compared to healthy comparison individuals. Single-cell transcriptomics revealed a lineage bias toward ChP fate in BD hCOs, accompanied by structural enlargement observed in both BD hChPOs and ChP in sMRI scans from individuals with BD. Comprehensive transcriptomic profiling implicates early hyperactivation of the Hippo signaling pathway in neural progenitor cells as a convergent mechanism driving ChP overgrowth. Whole-genome and genome-wide association study analyses highlight recurrent genetic variants in Hippo regulators, including STK4 and YAP1 , suggesting genetic priming. BD hChPOs exhibit disrupted epithelial junctions and altered in vitro CSF secretion. These findings position the ChP as a genetically and developmentally predisposed to pathology in BD and highlight organoids as a platform for translational discovery in diagnostics and therapeutics.
Open AccessDysregulation of Hippo Signaling Pathway as a Convergent Mechanism Underlying Choroid Plexus Defects in Bipolar Disorder
Bipolar disorder (BD) is a prevalent and highly heritable psychiatric condition. Developmental mechanisms are implicated but the specific molecular origins remain unclear. The choroid plexus (ChP), which regulates cerebrospinal fluid (CSF) and brain homeostasis, has been implicated in BD, but its role is poorly understood. Here, we identify aberrant expansion of ChP in human cortical (hCOs) and ChP organoids (hChPOs) derived from, and in vivo structural magnetic resonance imaging (sMRI) scans of, individuals with BD compared to healthy comparison individuals. Single-cell transcriptomics revealed a lineage bias toward ChP fate in BD hCOs, accompanied by structural enlargement observed in both BD hChPOs and ChP in sMRI scans from individuals with BD. Comprehensive transcriptomic profiling implicates early hyperactivation of the Hippo signaling pathway in neural progenitor cells as a convergent mechanism driving ChP overgrowth. Whole-genome and genome-wide association study analyses highlight recurrent genetic variants in Hippo regulators, including STK4 and YAP1 , suggesting genetic priming. BD hChPOs exhibit disrupted epithelial junctions and altered in vitro CSF secretion. These findings position the ChP as a genetically and developmentally predisposed to pathology in BD and highlight organoids as a platform for translational discovery in diagnostics and therapeutics.
- 14 January 2026
- Published by Elsevier in Developmental Cell
- Vol. 61 (1) , 9-11
The metabolic mood: Cholesterol homeostasis as a convergence point for depression risk
- 14 January 2026
- Published by Elsevier in Developmental Cell
- Vol. 61 (1) , 9-11
The metabolic mood: Cholesterol homeostasis as a convergence point for depression risk
- 30 December 2025
- Published by Elsevier in Cell Stem Cell
- Vol. 33 (1) , 91-107.e9
Generation of human pineal gland organoids with melatonin production for disease modeling
- 30 December 2025
- Published by Elsevier in Cell Stem Cell
- Vol. 33 (1) , 91-107.e9
Generation of human pineal gland organoids with melatonin production for disease modeling
- Open Access
- 24 December 2025
- Published by Springer Nature in Research Square
Targeting ATP synthase c-subunit leak reverses brain metabolism of bipolar disorder
Bipolar Disorder (BD) is characterized by dysregulated emotional and energy states and is associated with abnormal mitochondrial function and elevated lactate levels in serum, cerebrospinal fluid, and brain tissue. Here, we report that induced pluripotent stem cells (iPSCs) and human cortical organoids (hCOs) derived from individuals with BD exhibit upregulation of the ATP synthase c-subunit (ACLC), leading to increased aerobic glycolytic leak metabolism. BD-hCOs display elevated lactate secretion, enhanced protein synthesis, increased ribosomal biogenesis, and disrupted ventricular zone architecture, consistent with early neurodevelopmental abnormalities. Both treatment with lithium, a first-line therapy for BD, and Dexpramipexole (Dex), a known ATP synthase inhibitor, suppressed ACLC-mediated conductance and reduced metabolic leak, protein synthesis, and hCO hyperexcitability. Consistent with these in vitro findings, in vivo data from individuals with BD revealed elevated blood lactate levels and neuroimaging markers of increased brain oxidative metabolism. These results implicate ACLC as a treatable driver of metabolic, electrophysiological, and structural brain developmental abnormalities in BD.
- 24 December 2025
- Published by Springer Nature in Research Square
Open AccessTargeting ATP synthase c-subunit leak reverses brain metabolism of bipolar disorder
Bipolar Disorder (BD) is characterized by dysregulated emotional and energy states and is associated with abnormal mitochondrial function and elevated lactate levels in serum, cerebrospinal fluid, and brain tissue. Here, we report that induced pluripotent stem cells (iPSCs) and human cortical organoids (hCOs) derived from individuals with BD exhibit upregulation of the ATP synthase c-subunit (ACLC), leading to increased aerobic glycolytic leak metabolism. BD-hCOs display elevated lactate secretion, enhanced protein synthesis, increased ribosomal biogenesis, and disrupted ventricular zone architecture, consistent with early neurodevelopmental abnormalities. Both treatment with lithium, a first-line therapy for BD, and Dexpramipexole (Dex), a known ATP synthase inhibitor, suppressed ACLC-mediated conductance and reduced metabolic leak, protein synthesis, and hCO hyperexcitability. Consistent with these in vitro findings, in vivo data from individuals with BD revealed elevated blood lactate levels and neuroimaging markers of increased brain oxidative metabolism. These results implicate ACLC as a treatable driver of metabolic, electrophysiological, and structural brain developmental abnormalities in BD.